Clinical Trial

PREdiabetes GLycemic Impact and Data Evaluation

Study acronym: PRE-GLIDE

Recruiting

Summary

This prospective, randomized controlled trial evaluates whether real-time continuous glucose monitoring (CGM) improves glycemic control and lifestyle adherence in adults with prediabetes compared to conventional self-monitoring methods over a 3-month period. By analyzing metabolic markers and behavioral data, the study aims to determine the effectiveness of 24-hour monitoring as a personalized tool that increases patient adherence to lifestyle changes compared to conventional SMBG methods.

Protocol Amendment History 2 changes

notable Primary completion pushed: 2026-12-31 -> 2027-05-31 2026-07-01

minor Completion pushed: 2027-01-31 -> 2027-06-30 2026-07-01

Trial Details

NCT Number	NCT07599072
Lead Sponsor	Nazarii Kobyliak Collaborators: COR-Medical LLC, Iridium LLC
Conditions	Pre Diabetic, Obesity & Overweight, Insulin Resistance
Enrollment	80 participants
Start Date	2026-07-01
Primary Completion	2027-05-31 (estimated)
Study Completion	2027-06-30 (estimated)
Updated on ClinicalTrials.gov	2026-06-30